Showing 8941-8950 of 20387 results for "".
- Study Finds Replacing Ultra-Processed Foods in Diet Reduces Type 2 Diabetes Riskhttps://reachmd.com/news/study-finds-replacing-ultra-processed-foods-in-diet-reduces-type-2-diabetes-risk/2468200/Credit: Pixabay/CC0 Public Domain People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2
- European Partnership to Combat Type 1 Diabetes Receives €23 Million IHI Fundinghttps://reachmd.com/news/european-partnership-to-combat-type-1-diabetes-receives-23-million-ihi-funding/2462279/The T1D ChallengeType 1 Diabetes (T1D) is a growing concern, particularly among children and young people, leading to lifelong implications. Recent years, including during the COVID-19 pandemic, have witnessed an increase in T1D cases. T1D profoundly impacts th
- Addressing Therapeutic Inertia in Diabetes Care: Strategies in Resource-Limited Settingshttps://reachmd.com/news/therapeutic-inertia-diabetes-resource-limited-settings/2484726/A therapeutic inertia study in Ethiopia found that 67.2% of ambulatory adults with type 2 diabetes experienced therapeutic inertia, revealing a large gap in timely treatment
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://reachmd.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- Diabetes Patients Treated with Insulin Have 60% Increased Risk of Serious Injury, Suggests Studyhttps://reachmd.com/news/diabetes-patients-treated-with-insulin-have-60-increased-risk-of-serious-injury-suggests-study/2467456/Researchers have found in a new study that individuals with type 2 diabetes treated with insulin had a 65% increased risk for injuries serious enough to cause hospitalization, and the risk was 60% higher for those with type 1 diabetes. "We need people with diabetes, health professionals and
- A Healthy Lifestyle May Counteract Diabetes-Associated Brain Aginghttps://reachmd.com/news/a-healthy-lifestyle-may-counteract-diabetes-associated-brain-aging/2467987/Type 2 diabetes and prediabetes are associated with accelerated brain ageing, according to a new study from Karolinska Institutet in Sweden published in the journal Diabetes Care. The good news is that this may be counteracted by a healthy lifestyle. Type 2 diabe
- Possible Explanation for Link Between Diabetes and Alzheimer'shttps://reachmd.com/news/possible-explanation-for-link-between-diabetes-and-alzheimers/2467761/People with type 2 diabetes are at increased risk of Alzheimer's disease and other cognitive problems. A new study led by Umeå University, Sweden, shows that the reason may be that people with type 2 diabetes have more difficulty getting rid of a protein that may cause the disease.
- Blood Test Could Determine Diabetes Riskshttps://reachmd.com/news/blood-test-could-determine-diabetes-risks/2457273/A blood test could potentially be used to assess a patient's risk of type 2 diabetes, a new study from Edith Cowan University (ECU) has found.The most commonly used inflammatory biomarker currently used to predict the risk of type 2 diabetes is high-sensitiv
- Examining the Differential Influence of Maternal Diabetes on Adipokine Profiles in Maternal Serum and Cord Bloodhttps://reachmd.com/news/examining-the-differential-influence-of-maternal-diabetes-on-adipokine-profiles-in-maternal-serum-and-cord-blood/2471420/Maternal diabetes, encompassing both type 2 diabetes and gestational diabetes, plays a significant role in shaping the metabolic environment of both the mother and her newborn. By influencing levels of adiponectin, leptin, insulin, and glucose, these conditions set
- GLP-1 Receptor Agonists and Cardiorenal Outcomes in Type 1 Diabeteshttps://reachmd.com/news/glp-1-receptor-agonists-and-cardiorenal-outcomes-in-type-1-diabetes/2487159/Key Takeaways GLP-1 receptor agonist initiation was associated with lower risks of major adverse cardiovascular events and end-stage kidney disease than noninitiation. Initiation was also associated with lower hospitalization for heart failure and majo